Francesca Fontana
speaker
2,691 appearances
52 recordings
1 series
first heard Aug 2017
last heard Feb 2025
Francesca Fontana’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
I'm Francesca Fontana for The Wall Street Journal, and this is What's News in Markets, our look at the biggest stock moves of the week and the news that drove them.
voice-verified
Let's get to it.
voice-verified
The first half of 2024 is coming to an end, and it really was a monster first half for the stock market.
voice-verified
Going into this year, investors had two big bets, one on the AI buzz that started last year, and one on the Federal Reserve lowering interest rates at a good clip, maybe half a dozen times.
voice-verified
The bet on AI was right on the money, as we've seen from the bonkers demand for Nvidia chips and that company's meteoric rise in valuation.
voice-verified
The interest rate bet, though, got dampened a little bit, as the Fed has held off on rate cuts so far.
voice-verified
But all in all, Nvidia has helped power the S&P 500 roughly 15% higher this year, in spite of all the central bank business.
voice-verified
The major indexes ended the first half of 2024 higher.
voice-verified
The Nasdaq gained 18%, the S&P 500 rose 14%, and the Dow Jones Industrial Average added 4%.
voice-verified
Mid-year is also a pretty good time to reflect and check in on the buzzy stocks we've seen this year, like Novo Nordisk, which is the Danish pharma company behind hugely popular drugs that are being used for weight loss, like Ozempic.
voice-verified
Yes, the jingle is already in my head.
voice-verified
That wild success can also be seen in its stock price.
voice-verified
The company's U.S.-listed shares are up more than 80% so far this year.
voice-verified
Novo Nordisk also makes a similar drug, Wagovi, and that one got a big win this week in China.
voice-verified
The company will now be able to sell Wegovy in the country, aka the world's second largest economy.
voice-verified
Good thing for the company, too, because demand for these kinds of drugs is surging there.
voice-verified
And it's already been selling Ozempic in China since it was approved to treat diabetes there in 2021.
voice-verified
No launch date was announced along with the news on Tuesday, and neither were any details of how much of the drug will be available.
voice-verified
And that brings up the other side of the coin.
voice-verified
On one side is the huge popularity of these treatments.
voice-verified
Showing 1221–1240 of 2,691 · page 62 of 135
← Previous
Next →